physostigmine has been researched along with Cognitive Decline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abels, W; Akyüz, L; Borchers, F; Brockhaus, WR; Ely, EW; Fabian, M; Feldheiser, A; Kipping, V; Knaak, C; Kunzmann, K; Menon, DK; Mertens, M; Müller, O; Piper, SK; Pratschke, J; Shadenok, A; Spies, CD; Wernecke, KD; Wiebach, J | 1 |
Amaral, JD; Bernardi, J; Brandão, R; Costa, L; da Costa, M; Fiuza, T; Pereira, ME; Ribeiro, MF; Rodrigues, CMP | 1 |
Barak, S; Becker, KG; Becker, RE; Fukui, K; Greig, NH; Hoffer, BJ; Holloway, HW; Lehrmann, E; Li, Y; Luo, Y; Perez, E; Pick, CG; Rubovitch, V; Tamargo, IA; Tweedie, D; Van Praag, H; Wood, WH; Yu, QS; Zhang, Y | 1 |
Chang, MY; Greig, NH; John, V; Maccecchini, ML; Pan, C; Zetterberg, H | 1 |
2 trial(s) available for physostigmine and Cognitive Decline
Article | Year |
---|---|
Physostigmine for prevention of postoperative delirium and long-term cognitive dysfunction in liver surgery: A double-blinded randomised controlled trial.
Topics: Adolescent; Adult; Cognitive Dysfunction; Delirium; Humans; Liver; Physostigmine; Postoperative Complications | 2021 |
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inflammation Mediators; Male; Peptide Fragments; Physostigmine; Rats; Rats, Inbred F344; tau Proteins | 2012 |
2 other study(ies) available for physostigmine and Cognitive Decline
Article | Year |
---|---|
N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin.
Topics: Acetylcholinesterase; Acetylcysteine; Animals; Cerebral Cortex; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Immunohistochemistry; Male; Maze Learning; Mice; Motor Activity; Neuronal Plasticity; Neuroprotective Agents; Oxidative Stress; Physostigmine; Receptor, trkB; Streptozocin; Superoxide Dismutase | 2017 |
Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.
Topics: Animals; Brain Concussion; Cholinergic Agents; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal; Gene Expression Regulation; Glutamic Acid; Hippocampus; Humans; Lipid Peroxidation; Maze Learning; Mice; Neurons; Oxidative Stress; Physostigmine | 2016 |